| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849119 | American Heart Journal | 2007 | 7 Pages |
Abstract
In patients with clinical evident vascular disease, lower adiponectin levels were associated with a lower cardiovascular risk. Therefore, it may be hypothesized that the potential antiatherosclerotic properties of adiponectin do not apply for patients with already established vascular disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gideon R. MD, Yolanda MD, PhD, Jobien K. MD, PhD, Michael Edlinger, Frank L.J. MD, PhD,